Company Profile
Updated: 30-OCT-09Arpida AG
International public company
Duggingerstrasse 23, Reinach, CH-4153, Switzerland
()41 061 417 96 60, 41 061 417 96 61 fax, http://www.arpida.ch/
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Biopharmaceutical company with interests in the research, development, manufacture and distribution of antibacterial drugs
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Gentium Announces New Board of Directors and Interim CEO.
Business Wire; 11/9/2009; 1248 words; ...Khalid Islam - Former President and Chief Executive Officer of Arpida Ltd, has held various executive functions in Marion Merrell...pharmaceutical industries. Dr. Islam is the founder of Ki Consulting AG and co-founder of Sirius Healthcare Partners GmbH, both of...
Other News To Note.
BIOWORLD Today; 11/3/2009; 2342 words; ...of Hepatology. A prodrug form of isatoribine is being developed by Anadys and partner, Novartis AG, of Basel, Switzerland, to treat HCV. o Arpida Ltd., of Basel, Switzerland, said the FDA granted fast-track status to intravenous iclaprim...
Activaero Closes a [euro] 10.7 Million ($16 million) Series A Financing.
Business Wire; 10/29/2009; 1402 words; ...solutions for solid dosage forms. About BioMedPartners AG BioMedPartners AG is a leading independent European venture capital firm...have already either successfully completed an IPO (Arpida AG, Santhera Pharmaceuticals AG) or have been acquired...
Other News To Note.(Bio-Rad Laboratories Inc. acquires Biotest AG)(Eurogentec acquires AnaSpec Inc)(EMD Chemicals Inc. collabrate with MitoSciences Inc.)
BIOWORLD Today; 10/26/2009; 1570 words; o Arpida A/S, of Reinach, Switzerland, withdrew...recommending iclaprim's approval in the U.S. Arpida, which laid off most of its work force earlier...certain diagnostic businesses of Biotest AG, of Dreieich, Germany, for C45 million...
Evolva Closes $27.8M Series B as Arpida Merger Plans Solidify.(Eurand NV)
BIOWORLD Today; 10/23/2009; 1154 words; ...as part of its move to merge with Arpida AG. Evolva said it is continuing in...closing after approval of the merger by Arpida shareholders. The Series B funding...Sunstone Capital. The beleaguered Arpida and Evolva agreed to the merger in...
Recent News Articles
- Researchers from Arpida AG provide details of new studies and findings in the area of drug development.
Biotech Week - March 25, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning